2006
DOI: 10.1681/asn.2006060658
|View full text |Cite
|
Sign up to set email alerts
|

O-Glycosylation of Serum IgA1 Antibodies against Mucosal and Systemic Antigens in IgA Nephropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
66
0
7

Year Published

2007
2007
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 112 publications
(76 citation statements)
references
References 30 publications
3
66
0
7
Order By: Relevance
“…These in silico predictions coupled with previous in vitro data demonstrating modulation of IgA1 O-galactosylation by Th2 cytokines and IL-6 36,37 , as well as our previous observation that IgA1 O-galactosylation varies depending on the site of antigen encounter and B cell activation 38 , are consistent with an effect of the H1 haplotype on transcriptional control of C1GALT1 particularly in IgA1-committed B cells.…”
Section: Discussionsupporting
confidence: 87%
“…These in silico predictions coupled with previous in vitro data demonstrating modulation of IgA1 O-galactosylation by Th2 cytokines and IL-6 36,37 , as well as our previous observation that IgA1 O-galactosylation varies depending on the site of antigen encounter and B cell activation 38 , are consistent with an effect of the H1 haplotype on transcriptional control of C1GALT1 particularly in IgA1-committed B cells.…”
Section: Discussionsupporting
confidence: 87%
“…After tonsillar stimulation, patients with IgAN, especially those suffering from macroscopic hematuria, had high levels of serum SIgA and elevated salivary levels of SIgA [28,29]. High sera SIgA concentrations correlated with macroscopic hematuria in IgAN [26,30]. Deposition of SIgA in the mesangium was also observed in patients with IgAN and the eluate of a nephrectomized transplanted kidney from a patient with IgAN contained a 120-fold accumulation of SIgA compared with IgA1 [2,6,27].…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies focused on the pathogenic role of aberrant glycosylated IgA in IgAN [7,8,9], which is deposited in mesangial areas to induce various immune inflammatory responses in IgAN, including activation of the complement path way and stimulation of mesangial cells to produce cytokines and chemokines [10,11,12,13]. However, whether patients with SIgA deposition have similar clinical pathological characteristics to patients with IgA deposition, and whether SIgA has a similar pathogenic role to IgA in IgAN are unknown.…”
Section: Introductionmentioning
confidence: 99%
“…The origin of the poor galactosylated IgA1s is still a not resolved question. Several studies have documented a significant difference in IgA1s generated in the systemic compartment with respect to the IgA1s generated on the mucosal surface [48] . Mucosal IgAs are predominantly polymeric (pIgA), while systemic IgAs are monomeric.…”
Section: Salvadori M Et Al Pathophysiology Of Nephropathymentioning
confidence: 99%